Company / Current Liabilities per Share
Nurix Therapeutics, Inc. Current Liabilities per Share History
FY2019-FY2025 · Annual data · Source: SEC filings
At a glance
Latest annual filing availableLatest Current Liabilities per Share
$1.14
FY2025
5-year range
$1.14 / $1.97
FY2021-FY2025
Trend
-42.1%
vs FY2024
Sector context
#106 of 210
Health Care
What the data says
At $1.14, Nurix Therapeutics, Inc.'s current liabilities per share ranks #105 of 210 in the Health Care sector. Current Liabilities per Share has fluctuated over the past 7 years, ranging from $1.14 in FY2025 to $12.39 in FY2020.
Based on SEC 10-K filings.
1.14 in FY2025 with a 5-year CAGR of -37.9%.
Improved from $1.84 to $1.14 over the past 2 years.
Health Care sector context is included.
Current Liabilities per Share over time
Growth rates
- 3-Year CAGR
- -10.4%
- 5-Year CAGR
- -37.9%
- 10-Year CAGR
- -
Sector benchmark
-92.8% below sector average
Key checks
Key Insights
- In FY2025, current liabilities per share decreased 42.1% year-over-year.
- Ranks #106 out of 210 companies in the Health Care sector.
- Peak current liabilities per share was recorded in FY2020.
Company context
Key Data Points
- Altman Z-Score -0.35 (distress zone, below 1.8 threshold)
Data sourced from SEC EDGAR filings. Not investment advice.
Annual data
| Year | Current Liabilities per ShareValue | YoY GrowthYoY |
|---|---|---|
| FY2025 | $1.14 | -42.1% |
| FY2024 | $1.97 | +6.7% |
| FY2023 | $1.84 | +16.5% |
| FY2022 | $1.58 | -7.2% |
| FY2021 | $1.70 | -86.2% |
| FY2020 | $12.39 | +152.8% |
| FY2019 | $4.90 | - |
As of FY2025 · SEC 10-K · Updated Jun 30, 2026